Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • JBL vs GSK✓SelectedUSD · GSKJBL vs GSK performance historyLatest closeAs of-8.39%11/20
Stock and ETF performance explorer

JBL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+71.4%
GSK return
+53.4%
Excess return
+18.1%
Maximum drawdown
-41.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.4%-0.1%-8.3%-8.4%
7D-11.2%-5.3%-5.8%-11.5%
30D-19.6%-3.7%-16.0%-19.7%
3M-28.7%-7.3%-21.4%-28.6%
6M-34.6%-4.2%-30.3%-34.6%
YTD-0.9%+0.9%-1.7%-0.6%
1Y+17.4%+7.3%+10.1%+17.8%
3Y+71.4%+52.7%+18.7%+53.4%
All+71.4%+53.4%+18.1%+53.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling